This on-demand webinar explores FDA’s proposed mandatory GRAS notification framework, what increased oversight and transparency could mean for existing and future GRAS conclusions, and how manufacturers, ingredient suppliers, and brand owners can prepare as federal and state requirements continue to evolve.
Dylan Fronda, B.Sc., Toxicology
This on-demand webinar explores the growing tension between federal oversight and state-level enforcement, what recent legislative activity signals for the future of GRAS, and how these changes may impact manufacturers, ingredient suppliers, and brand owners operating in the U.S. market.
Dylan Fronda, B.Sc., Toxicology
Join us for this webinar as we explore the rising interest in GLP-1 inspired supplements and what it takes to bring these concepts to market. We’ll cover ingredient mechanisms, delivery formats, regulatory feasibility across North America and Europe, and clinical strategies to support metabolic health and appetite-related claims.
Dylan Fronda, B.Sc., Toxicology & Moustafa Kardjadj, Ph.D.
Join us for this webinar as we explore Health Canada’s draft Good Manufacturing Practices (GMP) guide for Natural Health Products (NHPs) and highlight proposed revisions that could impact regulatory compliance and business operations. We’ll discuss key issues and encourage industry feedback before the consultation period ends on December 16, 2024.
William Morkel, BSc, Director of Quality & Compliance
